Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $147.24 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $63.66 | 4 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $42.33 | 3 | $0 (2018) |
| Alkermes, Inc. | $24.94 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $16.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $108.64 | 8 | Vanda Pharmaceuticals Inc. ($42.33) |
| 2017 | $38.60 | 2 | Otsuka America Pharmaceutical, Inc. ($22.29) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: CNS | ||||||
| 10/24/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Schizophrenia | ||||||
| 07/25/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: CNS | ||||||
| 06/27/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/26/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Schizophrenia | ||||||
| 05/30/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Schizophrenia | ||||||
| 04/19/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: PSYCHIATRY | ||||||
| 01/25/2017 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Neuroscience | ||||||
About Dr. Mario Hasaj, MD
Dr. Mario Hasaj, MD is a Cognitive & Behavioral healthcare provider based in Townshend, Vermont. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043263809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mario Hasaj, MD has received a total of $147.24 in payments from pharmaceutical and medical device companies, with $108.64 received in 2018. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($147.24).
Practice Information
- Specialty Cognitive & Behavioral
- Other Specialties Psychiatry
- Location Townshend, VT
- Active Since 05/19/2006
- Last Updated 01/06/2012
- Taxonomy Code 103TB0200X
- Entity Type Individual
- NPI Number 1043263809
Products in Payments
- Fanapt (Drug) $42.33
- ABILIFY MAINTENA (Drug) $37.29
- REXULTI (Drug) $26.37
- Aristada 441 mg (Drug) $24.94
- INVEGA TRINZA (Drug) $16.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.